{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-04T07:10:35.909164+00:00","company":{"ticker":"CC","cik":1627223,"company_name":"Chemours Co"},"pagination":{"limit":100,"returned":14,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"fddd9a81d07ef3ea5f470e5546c1eab3ee354614","cik":1627223,"ticker":"CC","company_name":"Chemours Co","filed_at":"2026-05-05T23:59:59+00:00","payload":{"eps_text":"$0.19 per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"Net Loss attributable to Chemours of $29 million, or $0.19 per diluted share","period_text":"first quarter 2026","report_date":"2026-05-05","result_type":"reported_results","revenue_text":"$1.4 billion"},"claim":"Chemours Co reported first quarter 2026 results: revenue $1.4 billion, net income Net Loss attributable to Chemours of $29 million, or $0.19 per diluted share, EPS $0.19 per diluted share.","evidence_excerpt":"and Advanced Performance Materials (“APM”), today announced its financial results for the first quarter 2026. Key First Quarter 2026 Results & Recent Highlights 1 • Net Sales of $1.4 billion, slightly up compared to the corresponding prior-year quarter, with TSS reporting record first quarter results, with continued double-digit year-over-year sales growth in","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001627223-26-000010","anchor_url":"https://secwatch.observer/filing/0001627223-26-000010#claim-fddd9a81d07ef3ea5f470e5546c1eab3ee354614","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1627223/000162722326000010/0001627223-26-000010-index.htm"},{"fact_type":"material_agreement","fact_key":"7fe874283dfa56c21729ff988df3b74ac5aa4800","cik":1627223,"ticker":"CC","company_name":"Chemours Co","filed_at":"2026-01-16T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreements","agreement_type":"asset_purchase","counterparty":"Century Wind Power Co., Ltd., Century Iron and Steel Industrial Co., Ltd., Century Huaxin Wind Energy Co., Ltd. and Mr. Lai Wen-Hsiang","effective_date":"2026-01-15","item_codes_triggered":["1.01"],"value_text":"approximately $360 million"},"claim":"Chemours Co entered into Purchase Agreements with Century Wind Power Co., Ltd., Century Iron and Steel Industrial Co., Ltd., Century Huaxin Wind Energy Co., Ltd. and Mr. Lai Wen-Hsiang valued at approximately $360 million (effective 2026-01-15).","evidence_excerpt":"On January 15, 2026 (the “Effective Date”), The Chemours Company (the “Company”), through its subsidiary, The Chemours (Taiwan) Company Limited (“Seller”), entered into four separate Real Estate Sale and Purchase Agreements (collectively, the “Purchase Agreements”) with four affiliated entities: Century Wind Power Co., Ltd., Century Iron and Steel Industrial Co., Ltd., Century Huaxin Wind Energy Co., Ltd. and Mr. Lai Wen-Hsiang (collectively, the “Buyers”) to sell ten parcels of land in Kuan Yin, Taiwan (collectively, the “Property”) for a total purchase price of approximately $360 million.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-014624","anchor_url":"https://secwatch.observer/filing/0001193125-26-014624#claim-7fe874283dfa56c21729ff988df3b74ac5aa4800","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1627223/000119312526014624/0001193125-26-014624-index.htm"},{"fact_type":"debt_financing","fact_key":"5c76f294c31958de18220b764292f537c888bcd1","cik":1627223,"ticker":"CC","company_name":"Chemours Co","filed_at":"2025-10-16T23:59:59+00:00","payload":{"counterparty":"JPMorgan Chase Bank, N.A., as administrative agent","effective_date":"2025-10-15","event":"amendment","instrument_type":"term_loan","interest_rate_text":"adjusted Term SOFR + 3.50% or adjusted base rate plus 2.50%","item_codes_triggered":["2.03"],"maturity_text":"October 15, 2032","principal_text":"$1,050,000,000"},"claim":"Chemours Co amended term loan of $1,050,000,000 with JPMorgan Chase Bank, N.A., as administrative agent at adjusted Term SOFR + 3.50% or adjusted base rate plus 2.50% maturing October 15, 2032.","evidence_excerpt":"The Amendment extended the maturity date of the Company’s $1,050,000,000 senior secured U.S. dollar-denominated term loan facility (the “Term Loan B-3 US$ Facility”) from August 18, 2028 to October 15, 2032.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-25-240643","anchor_url":"https://secwatch.observer/filing/0001193125-25-240643#claim-5c76f294c31958de18220b764292f537c888bcd1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1627223/000119312525240643/0001193125-25-240643-index.htm"},{"fact_type":"executive_change","fact_key":"4c2650c53d","cik":1627223,"ticker":"CC","company_name":"Chemours Co","filed_at":"2025-03-10T23:59:59+00:00","payload":{"action":"not seek re-election","action_category":"departure","departure_tone":"routine","effective_date":null,"interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Guillaume Pepy departed as Director at Chemours Co.","evidence_excerpt":"On March 9, 2025, Guillaume Pepy notified the Board of Directors (the “Board”) of The Chemours Company (the “Company”) of his decision not to seek re-election to the Board at the Company’s 2025 Annual Meeting of Shareholders, when his current term expires.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000950170-25-036513","anchor_url":"https://secwatch.observer/filing/0000950170-25-036513#claim-4c2650c53d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1627223/000095017025036513/0000950170-25-036513-index.htm"},{"fact_type":"executive_change","fact_key":"14cc09ca3a","cik":1627223,"ticker":"CC","company_name":"Chemours Co","filed_at":"2025-02-18T23:59:59+00:00","payload":{"action":"not seeking re-election","action_category":"departure","departure_tone":"routine","effective_date":null,"interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Curtis V. Anastasio departed as Director at Chemours Co.","evidence_excerpt":"On February 13, 2025, Curtis V. Anastasio notified the Board of Directors (the \"Board\") of The Chemours Company (the \"Company\") of his decision not to seek re-election to the Board at the Company's 2025 Annual Meeting of Stockholders, when his current term expires.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000950170-25-021792","anchor_url":"https://secwatch.observer/filing/0000950170-25-021792#claim-14cc09ca3a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1627223/000095017025021792/0000950170-25-021792-index.htm"},{"fact_type":"executive_change","fact_key":"ce9afe2b40","cik":1627223,"ticker":"CC","company_name":"Chemours Co","filed_at":"2025-02-11T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-02-19","interim":false,"role":"member of the Board","role_category":"director","successor_name":null,"successor_named":false},"claim":"Leslie M. Turner was appointed as member of the Board at Chemours Co.","evidence_excerpt":"appointed Leslie M. Turner as a member of the Board, effective February 19, 2025.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000950170-25-017985","anchor_url":"https://secwatch.observer/filing/0000950170-25-017985#claim-ce9afe2b40","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1627223/000095017025017985/0000950170-25-017985-index.htm"},{"fact_type":"executive_change","fact_key":"82ff19f777","cik":1627223,"ticker":"CC","company_name":"Chemours Co","filed_at":"2025-01-07T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-01-03","interim":false,"role":"member of the Board","role_category":"director","successor_name":null,"successor_named":false},"claim":"Joseph D. Kava was appointed as member of the Board at Chemours Co.","evidence_excerpt":"On January 3, 2025, the Board of Directors (the “Board”) of The Chemours Company (the “Company”) appointed Joseph D. Kava as a member of the Board, effective January 3, 2025.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000950170-25-002553","anchor_url":"https://secwatch.observer/filing/0000950170-25-002553#claim-82ff19f777","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1627223/000095017025002553/0000950170-25-002553-index.htm"},{"fact_type":"executive_change","fact_key":"61cbc77447","cik":1627223,"ticker":"CC","company_name":"Chemours Co","filed_at":"2024-07-25T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-08-12","interim":false,"role":"Controller and Chief Accounting Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"David A. Will was appointed as Controller and Chief Accounting Officer at Chemours Co.","evidence_excerpt":"On July 23, 2024, David A. Will was appointed as Controller and Chief Accounting Officer (principal accounting officer) of The Chemours Company (the “Company”) effective as of August 12, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-24-086564","anchor_url":"https://secwatch.observer/filing/0000950170-24-086564#claim-61cbc77447","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1627223/000095017024086564/0000950170-24-086564-index.htm"},{"fact_type":"executive_change","fact_key":"3a208bca1c","cik":1627223,"ticker":"CC","company_name":"Chemours Co","filed_at":"2024-06-13T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-06-12","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Livingston \"Tony\" Satterthwaite was appointed as Director at Chemours Co.","evidence_excerpt":"On June 12, 2024, the Board of Directors (the “Board”) of The Chemours Company (the “Company”) appointed Livingston “Tony” Satterthwaite as a member of the Board, effective June 12, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-24-073084","anchor_url":"https://secwatch.observer/filing/0000950170-24-073084#claim-3a208bca1c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1627223/000095017024073084/0000950170-24-073084-index.htm"},{"fact_type":"executive_change","fact_key":"7fa4d90f9c","cik":1627223,"ticker":"CC","company_name":"Chemours Co","filed_at":"2024-06-05T23:59:59+00:00","payload":{"action":"will continue serving as","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2024-07-01","interim":false,"role":"Senior Vice President & Chief Enterprise Transformation Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Matthew Abbott changed role as Senior Vice President & Chief Enterprise Transformation Officer at Chemours Co.","evidence_excerpt":"Mr. Hostetter succeeds Matthew Abbott, who has served as the Interim Chief Financial Officer (principal financial and accounting officer) since February 28, 2024. Mr. Abbott will continue serving as the Company’s Senior Vice President & Chief Enterprise Transformation Officer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-24-069063","anchor_url":"https://secwatch.observer/filing/0000950170-24-069063#claim-7fa4d90f9c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1627223/000095017024069063/0000950170-24-069063-index.htm"},{"fact_type":"executive_change","fact_key":"b74ccdca92","cik":1627223,"ticker":"CC","company_name":"Chemours Co","filed_at":"2024-06-05T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-01","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":"Matthew Abbott","successor_named":true},"claim":"Shane Hostetter was appointed as Chief Financial Officer at Chemours Co.","evidence_excerpt":"On May 31, 2024, the Board of Directors (the “Board”) of The Chemours Company (the “Company”) appointed Shane Hostetter as Chief Financial Officer, effective as of July 1, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-24-069063","anchor_url":"https://secwatch.observer/filing/0000950170-24-069063#claim-b74ccdca92","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1627223/000095017024069063/0000950170-24-069063-index.htm"},{"fact_type":"earnings_release","fact_key":"5d95345c42ccf8bffe966abf3339352c3a2b344f","cik":1627223,"ticker":"CC","company_name":"Chemours Co","filed_at":"2024-04-30T23:59:59+00:00","payload":{"eps_text":"$0.34 per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$52 million, or $0.34 per diluted share","period_text":"first quarter 2024","report_date":"2024-04-30","result_type":"reported_results","revenue_text":"$1.4 billion"},"claim":"Chemours Co reported first quarter 2024 results: revenue $1.4 billion, net income $52 million, or $0.34 per diluted share, EPS $0.34 per diluted share.","evidence_excerpt":"Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for the first quarter 2024. Key First Quarter 2024 Results • Net Sales of $1.4 billion, down 12% year-over-year • Net Income attributable to Chemours of $52 million, or $0.34 per diluted share, compared with $145 million, or $0.96 per diluted share, in the","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000950170-24-050569","anchor_url":"https://secwatch.observer/filing/0000950170-24-050569#claim-5d95345c42ccf8bffe966abf3339352c3a2b344f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1627223/000095017024050569/0000950170-24-050569-index.htm"},{"fact_type":"executive_change","fact_key":"adcf1ac34b","cik":1627223,"ticker":"CC","company_name":"Chemours Co","filed_at":"2024-04-25T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-04-23","interim":false,"role":"Senior Vice President and Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Jonathan S. Lock resigned as Senior Vice President and Chief Financial Officer at Chemours Co.","evidence_excerpt":"On April 23, 2024, Jonathan S. Lock resigned from all positions with The Chemours Company (the “Company”).","confidence":0.5,"filing_url":"https://secwatch.observer/filing/0001193125-24-114364","anchor_url":"https://secwatch.observer/filing/0001193125-24-114364#claim-adcf1ac34b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1627223/000119312524114364/0001193125-24-114364-index.htm"},{"fact_type":"earnings_release","fact_key":"2cecb0ea4c0b5498fd92d14af62127170d07d1d9","cik":1627223,"ticker":"CC","company_name":"Chemours Co","filed_at":"2024-03-28T23:59:59+00:00","payload":{"eps_text":"Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share","period_text":"fourth quarter and full year 2023","report_date":"2024-03-27","result_type":"reported_results","revenue_text":"Net Sales of $1.4 billion"},"claim":"Chemours Co reported fourth quarter and full year 2023 results: revenue Net Sales of $1.4 billion, net income Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share, EPS Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share.","evidence_excerpt":"The Chemours Company Reports Fourth Quarter and Full Year 2023 Results Wilmington, Del., March 27, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies (“TT”), Thermal & Specialized Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for the fourth quarter and full year 2023. Key Fourth Quarter 2023 Results • Net Sales of $1.4 billion, up 2% year-over-year • Net Loss attributable to Chemours of $18 million, or a loss of $0.12 per diluted share","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-24-037412","anchor_url":"https://secwatch.observer/filing/0000950170-24-037412#claim-2cecb0ea4c0b5498fd92d14af62127170d07d1d9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1627223/000095017024037412/0000950170-24-037412-index.htm"}]}